{"id":777,"date":"2021-04-16T16:44:27","date_gmt":"2021-04-16T19:44:27","guid":{"rendered":"https:\/\/wp.ufpel.edu.br\/labgrima\/?p=777"},"modified":"2021-04-16T17:06:23","modified_gmt":"2021-04-16T20:06:23","slug":"public-perception-of-the-sputnik-v-vaccine-in-argentina-and-latin-america-by-juan-martin-gonzalez-cabanas","status":"publish","type":"post","link":"https:\/\/wp.ufpel.edu.br\/labgrima\/2021\/04\/16\/public-perception-of-the-sputnik-v-vaccine-in-argentina-and-latin-america-by-juan-martin-gonzalez-cabanas\/","title":{"rendered":"Public perception of the Sputnik V vaccine in Argentina and Latin America by Juan Martin Gonz\u00e1lez Caba\u00f1as"},"content":{"rendered":"

This report aims to realize an overview of the\u00a0level of preference<\/strong>\u00a0and\u00a0confidence<\/strong>\u00a0by the public opinion regarding the Sputnik V vaccine in Argentina and other Latin America countries (Brazil, Mexico, Peru and Chile) based on available surveys.<\/p>\n

\"\"<\/figure>\n

\u00a0ARGENTINA<\/strong><\/p>\n

\n\n\n\n\n\n\n\n\n\n
\n

source<\/strong><\/p>\n

 <\/td>\n

level of preference<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
CELAG<\/a><\/td>\n75%\u00a0 (first place)<\/em><\/td>\nMarch 2021<\/td>\n<\/tr>\n
Poliarqu\u00eda<\/a><\/td>\n56%\u00a0 (first place)<\/em><\/td>\nMarch 2021<\/td>\n<\/tr>\n
Berensztein<\/a><\/td>\n26%\u00a0 (first place)<\/em><\/td>\nMarch 2021<\/td>\n<\/tr>\n
Real time Data<\/a><\/td>\n33%\u00a0 (first place)<\/em><\/td>\nFebruary 2021<\/td>\n<\/tr>\n
Giacobbe<\/a><\/td>\n42%\u00a0 (first place)<\/em><\/td>\nNovember 2020<\/td>\n<\/tr>\n
Opinaia<\/a><\/td>\n45%\u00a0 (first place)<\/em><\/td>\nOctober 2020<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

According to the present review of opinion polls published in recent months on perceptions regarding vaccines against Covid-19,\u00a0the Russian Sputnik V is the preferred vaccine by the Argentines\u00a0<\/strong>(with an advantage of 4 out of 6 surveys reviewed).<\/p>\n

\n\n\n\n\n\n
source<\/strong><\/td>\nlevel of confidence in the vaccine<\/strong>\u00a0\u00a0<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
Rouvier y Asociados<\/a><\/td>\n51%<\/td>\nMarch 2021<\/td>\n<\/tr>\n
Universidad de San Andr\u00e9s<\/a><\/td>\n61%<\/td>\nMarch 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

On the basis of the previous surveys it is inferred that the perception of the level of confidence in the vaccine the Sputnik V vaccine in Argentina is quite high.<\/p>\n

As we observed in the course of this tracking regarding the perception on coronavirus vaccines, over the months the opinion towards the Sputnik V vaccine has improved \u2013despite the notorious and irresponsible campaign by media and opposition leaders against this vaccine<\/a>\u2013 this aspect is surely related to the beginning of the vaccination plan by the Argentine government, in addition to being the main vaccine of the Argentine plan, Sputnik V did not present any major adverse results.<\/p>\n

So far,\u00a04.713.723 doses have been applied in Argentina<\/a>\u00a0(about 9% of its total population).<\/p>\n

Political polarization also led to different opinions about Covid vaccination, where a\u00a0preference was observed among supporters of the opposition<\/a>\u00a0(Juntos por el Cambio) towards the Pfizer and Oxford\/Astrazeneca vaccines, while those with more favorable positions toward the government (Frente de Todos) are more favorable toward the Sputnik V vaccine.<\/p>\n

\"\"<\/figure>\n

BRAZIL<\/strong><\/p>\n

\n\n\n\n\n
source<\/strong><\/td>\nlevel of preference<\/u><\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
DataPoder<\/a><\/td>\n7% (fourth place)<\/td>\nAugust 2020<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\n\n\n\n\n
source<\/strong><\/td>\nlevel of confidence in the vaccine<\/u><\/strong>\u00a0\u00a0<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
YouGov<\/a><\/td>\n56%<\/a><\/td>\nMarch 2021 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\"\"<\/figure>\n

M\u00c9XICO<\/strong><\/p>\n

\n\n\n\n\n\n\n

\n<\/strong>source<\/strong> <\/td>\n		level of preference<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
El Financiero<\/a><\/td>\n15% (second place)<\/td>\nFebruary 2021<\/td>\n<\/tr>\n
Gabinete de Comunicaci\u00f3n Estrat\u00e9gica<\/a>\u00a0(GCE)<\/td>\n18% (second place)<\/td>\nJanuary \u2013 March 2021 2020<\/td>\n<\/tr>\n
Mitofsky<\/a><\/td>\n17%( second place)<\/td>\nApril 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\n\n\n\n\n\n

\n<\/strong>source<\/strong> <\/td>\n		level of confidence in the vaccine<\/strong>\u00a0\u00a0<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
El Financiero<\/a><\/td>\n66%<\/td>\nAugust 2020<\/td>\n<\/tr>\n
YouGov<\/a><\/td>\n80%<\/td>\nNovember<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\"\"<\/figure>\n

PER\u00da<\/strong><\/p>\n

\n\n\n\n\n
source<\/strong><\/td>\nlevel of preference<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
IPSOS<\/a><\/td>\n19% (first place)<\/em><\/td>\nFebruary 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\n\n\n\n\n
source<\/strong><\/td>\nlevel of confidence in the vaccine<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
IPSOS<\/a><\/td>\n19%<\/td>\nFebruary 2021<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n
\"\"<\/figure>\n

CHILE<\/strong><\/p>\n

\n\n\n\n\n
\u00a0<\/u><\/strong>\u00a0source<\/strong>\u00a0\u00a0<\/u><\/strong><\/td>\nlevel of confidence in the vaccine<\/strong><\/td>\nperiod<\/strong><\/td>\n<\/tr>\n
Cadem<\/a>\u00a0\u00a0<\/u><\/strong><\/td>\n33%<\/u><\/td>\nJanuary 2021<\/u><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n

Conclusions<\/strong><\/p>\n

Based on the data provided by the surveys we can make certain inferences about our two parameters under study:<\/p>\n

\u2013\u00a0level of preference for the Sputnik V vaccine<\/strong>: in Argentina (by a large margin) and Peru it is the preferred vaccine, in Mexico it occupies a marked second place of preference, and in Chile and Brazil it is much more relegated in its position.<\/p>\n

\u2013\u00a0level of confidence in the Sputnik V vaccine<\/strong>: in general terms, according to public opinion studies carried out, the Sputnik V vaccine has a high degree of confidence in the Latin American countries analyzed<\/p>\n

In chronological observation, since last year to the present, we can see that so far the trend is towards the consolidation of the position of the Sputnik V vaccine in exposure, level of preference and confidence by the citizenship and governments in Latin America.<\/p>\n

According to this review of recent public opinion surveys, the Sputnik V vaccine is on the podium of the most reliable and preferred vaccines against Covid by Latin Americans.<\/p>\n

Other articles by\u00a0Juan Martin Gonz\u00e1lez Caba\u00f1as\u00a0published in Vision & Global Trends. International Institute for Global Analyses\u2019 website:<\/em><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

This report aims to realize an overview of the\u00a0level of preference\u00a0and\u00a0confidence\u00a0by the public opinion regarding the Sputnik V vaccine in Argentina and other Latin America countries (Brazil, Mexico, Peru and Chile) based on available surveys.<\/p>

Continue lendo<\/a><\/p>\n","protected":false},"author":636,"featured_media":779,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[75,21,28,1],"tags":[26,27,9,15],"class_list":["post-777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-expert-opinions","category-labgrima-expert","category-news","category-noticias","tag-geopolitics","tag-latin-america","tag-russia","tag-soft-power","nodate","item-wrap"],"jetpack_featured_media_url":"https:\/\/wp.ufpel.edu.br\/labgrima\/files\/2021\/04\/Vacina-russa-Sputnik-V-1080x675-1.jpg","_links":{"self":[{"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/posts\/777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/users\/636"}],"replies":[{"embeddable":true,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/comments?post=777"}],"version-history":[{"count":3,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/posts\/777\/revisions"}],"predecessor-version":[{"id":782,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/posts\/777\/revisions\/782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/media\/779"}],"wp:attachment":[{"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/media?parent=777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/categories?post=777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wp.ufpel.edu.br\/labgrima\/wp-json\/wp\/v2\/tags?post=777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}